Secondary Immune Thrombocytopenia Due to Mycoplasma pneumoniae Without Clinically Significant Evidence of Active Infection

• Published in: Curēus (Palo Alto, CA) CA), 2022-03, Vol.14 (3), p.e23551
• Main Authors: Park, Changsu L, Margaria, Bryan, Husnain, Muhammad
• Format: Article
• Language: English
• Subjects: Anemia; Antigens; Blood platelets; Case reports; Chicken pox; Clinical significance; Cytomegalovirus; Disease; Edema; Glycoproteins; Heart failure; Hematology; Hepatitis; Immune system; Immunoglobulins; Infections; Infectious Disease; Internal Medicine; Lupus; Patients; Pneumonia; Purpura; Steroids; Thrombocytopenia; Viral infections
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.23551

Immune thrombocytopenia (ITP) is a leading cause of isolated thrombocytopenia characterized by autoantibody-mediated destruction of platelets, impaired megakaryocyte function, and pathologic T-cell recognition of platelet antigens. Several triggers for ITP have been identified. Treatment of the inciting cause decreases the antibodies responsible for molecular mimicry, and these cases are usually associated with a better outcome with a decreased probability of progression to chronic ITP. infection is known to have extrapulmonary manifestations, and growing evidence suggests it can be a cause of secondary ITP. Many of the described cases report evidence of a pulmonary infection with severe mucosal bleeding. Here, we describe an interesting case of a patient presenting with isolated thrombocytopenia with mild mucosal bleeding, later found to be positive for immunoglobulin M without clinically significant evidence of active infection. Currently, mycoplasma testing is not routinely performed as a workup for ITP. However, clinicians may consider this before proceeding with more aggressive treatment for refractory ITP (i.e., prolonged immunosuppression, splenectomy). This case illustrates that mild/asymptomatic infection can also be associated with ITP.